To the top ^^ Close ^^

ISHA 2023 Virtual Educational Series: Neurologic Diseases Session

 

SLP’s Role in Assessment of Patients with Autoimmune Neurologic Diseases

 

Presented by: Abby Bowman, M.S. CCC-SLP

Abby Bowman is a speech-language pathologist currently practicing in the acute care setting within a large, level I trauma academic medical center. Abby Bowman’s primary clinical interests lie in the areas of adult dysphagia evaluation and management of medically complex patients. Additionally, she has interest in treating patients with acquired neurogenic speech, language, and cognitive-communication disorders. She obtained an MS in Speech Language & Learning from Northwestern University and a BS in Speech Pathology & Audiology from Miami University (Ohio).

 

Session length: One hour

 

Activity Description: This presentation discussed the SLPs role in assessment and management of patients with various autoimmune neurologic disease, including Myasthenia Gravis, Guillain Barre Syndrome, and Multiple Sclerosis, with emphasis on motor speech and swallowing impairments seen in the acute care setting.

 

Session Agenda: 

  • 0-10 minutes: Introduction to topic and review of the Nervous System and Autoimmune Disorders
  • 10-30 minutes: Myasthenia Gravis – epidemiology, diagnostic process + medical treatment, clinical considerations for the SLP
  • 30-40 minutes: Guillain Barre syndrome – epidemiology, diagnostic process + medical treatment, clinical considerations for the SLP
  • 40-50 minutes: Multiple Sclerosis – epidemiology, diagnostic process + medical treatment, clinical considerations for the SLP
  • 50-60 minutes: Overview of clinical considerations in acute care for autoimmune neurologic disorders

 

Learning Objectives: After attending the presentation, participants will be able to

  • Describe the etiology, diagnostic process, and common medical interventions associated with a variety of neurologic autoimmune diseases, including Myasthenia Gravis, Guillain-Barre Syndrome, and Multiple Sclerosis.
  • Describe potential speech and swallowing impairments expected in patients with these neurologic autoimmune diseases.
  • Describe clinical considerations for dysphagia assessment, treatment, and management for these patients in the acute care setting.

 

Disclosure Information:

  • Financial: Abby Bowman does not have a relevant financial relationship to disclose.
  • Nonfinancial: Abby Bowman does not have a relevant financial relationship to disclose.


Ready to register? Click here to sign up!

Introductory

.1  ASHA CEUs

 

All courses have been approved for ASHA CEUs. See each course description for the number of ASHA CEUs available. To report your ASHA CEUs or to receive confirmation of course completion, please complete the Participant Form for EACH course. This form can be found in the confirmation email you will receive upon program registration. The participant form will require completion of participant information, assessment of learning objectives and the course evaluation. You are required to attend the entire recorded course to obtain continuing education credit. Each participant form will be cross-checked with the viewing log to ensure participants viewed the entire course. Any individual who did not view the entire course will not receive credit and will be removed from the ASHA course report.  ASHA CEUs will be reported at the end of each month.

 

If you have any questions or concerns, don't hesitate to reach out to ISHA at membership@ishail.org or 312-644-0828.